Market Tracker

05/31 5:16pm ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

3.90
Delayed Data
As of 4:00pm ET
 -0.11 / -2.74%
Today’s Change
3.50
Today|||52-Week Range
8.79
-43.72%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close4.01
Today’s open4.06
Day’s range3.90 - 4.06
Volume17,742
Average volume (3 months)42,151
Market cap$53.4M
Dividend yield--
Data as of 4:00pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+43.37%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--Synergy CHC Corp0.000.00%
OCRXOcera Therapeutics I...+0.08+3.25%
BLRXBioLine RX Ltd-0.02-1.96%
AVEOAveo Pharmaceuticals...+0.02+1.71%
Data as of 4:00pm ET, 05/31/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts